These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 30035392)

  • 21. Functional characterization of a novel FGFR2 mutation, E731K, in craniosynostosis.
    Park J; Park OJ; Yoon WJ; Kim HJ; Choi KY; Cho TJ; Ryoo HM
    J Cell Biochem; 2012 Feb; 113(2):457-64. PubMed ID: 21928350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of human cranial osteoblast phenotype by FGF-2, FGFR-2 and BMP-2 signaling.
    Marie PJ; Debiais F; Haÿ E
    Histol Histopathol; 2002; 17(3):877-85. PubMed ID: 12168799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Soluble form of FGFR2 with S252W partially prevents craniosynostosis of the apert mouse model.
    Morita J; Nakamura M; Kobayashi Y; Deng CX; Funato N; Moriyama K
    Dev Dyn; 2014 Apr; 243(4):560-7. PubMed ID: 24259495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD4 T-cell transcriptome analysis reveals aberrant regulation of STAT3 and Wnt signaling pathways in rheumatoid arthritis: evidence from a case-control study.
    Ye H; Zhang J; Wang J; Gao Y; Du Y; Li C; Deng M; Guo J; Li Z
    Arthritis Res Ther; 2015 Mar; 17(1):76. PubMed ID: 25880754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FGFR2 signaling and the pathogenesis of acne.
    Melnik B; Schmitz G
    J Dtsch Dermatol Ges; 2008 Sep; 6(9):721-8. PubMed ID: 19000061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apert syndrome: the current role of prenatal ultrasound and genetic analysis in diagnosis and counselling.
    Athanasiadis AP; Zafrakas M; Polychronou P; Florentin-Arar L; Papasozomenou P; Norbury G; Bontis JN
    Fetal Diagn Ther; 2008; 24(4):495-8. PubMed ID: 19077386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Research advances in Apert syndrome.
    Das S; Munshi A
    J Oral Biol Craniofac Res; 2018; 8(3):194-199. PubMed ID: 30191107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of fibroblast growth factor receptor 2 ligand-binding specificity in Apert syndrome.
    Yu K; Herr AB; Waksman G; Ornitz DM
    Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14536-41. PubMed ID: 11121055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicogenetic study of Turkish patients with syndromic craniosynostosis and literature review.
    Nur BG; Pehlivanoğlu S; Mıhçı E; Calışkan M; Demir D; Alper OM; Kayserili H; Lüleci G
    Pediatr Neurol; 2014 May; 50(5):482-90. PubMed ID: 24656465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apert syndrome with omphalocele: a case report.
    Ercoli G; Bidondo MP; Senra BC; Groisman B
    Birth Defects Res A Clin Mol Teratol; 2014 Sep; 100(9):726-9. PubMed ID: 25045033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of N-cadherin and protein kinase C in osteoblast gene activation induced by the S252W fibroblast growth factor receptor 2 mutation in Apert craniosynostosis.
    Lemonnier J; Haÿ E; Delannoy P; Lomri A; Modrowski D; Caverzasio J; Marie PJ
    J Bone Miner Res; 2001 May; 16(5):832-45. PubMed ID: 11341328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imaging of Skeletal Disorders Caused by Fibroblast Growth Factor Receptor Gene Mutations.
    Sargar KM; Singh AK; Kao SC
    Radiographics; 2017 Oct; 37(6):1813-1830. PubMed ID: 29019756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Facial suture synostosis of newborn Fgfr1(P250R/+) and Fgfr2(S252W/+) mouse models of Pfeiffer and Apert syndromes.
    Purushothaman R; Cox TC; Maga AM; Cunningham ML
    Birth Defects Res A Clin Mol Teratol; 2011 Jul; 91(7):603-9. PubMed ID: 21538817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibroblast growth factors lead to increased Msx2 expression and fusion in calvarial sutures.
    Ignelzi MA; Wang W; Young AT
    J Bone Miner Res; 2003 Apr; 18(4):751-9. PubMed ID: 12674336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Craniosynostosis as a clinical and diagnostic problem: molecular pathology and genetic counseling.
    Kutkowska-Kaźmierczak A; Gos M; Obersztyn E
    J Appl Genet; 2018 May; 59(2):133-147. PubMed ID: 29392564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proline to arginine mutations in FGF receptors 1 and 3 result in Pfeiffer and Muenke craniosynostosis syndromes through enhancement of FGF binding affinity.
    Ibrahimi OA; Zhang F; Eliseenkova AV; Linhardt RJ; Mohammadi M
    Hum Mol Genet; 2004 Jan; 13(1):69-78. PubMed ID: 14613973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toward pathogenesis of Apert cleft palate: FGF, FGFR, and TGF beta genes are differentially expressed in sequential stages of human palatal shelf fusion.
    Britto JA; Evans RD; Hayward RD; Jones BM
    Cleft Palate Craniofac J; 2002 May; 39(3):332-40. PubMed ID: 12019011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The molecular and cellular basis of Apert syndrome.
    Liu C; Cui Y; Luan J; Zhou X; Han J
    Intractable Rare Dis Res; 2013 Nov; 2(4):115-22. PubMed ID: 25343114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin pattern of Apert fibroblasts in vitro.
    Bodo M; Carinci F; Baroni T; Becchetti E; Bellucci C; Giammarioli M; Pezzetti F; Tognon M; Carinci P
    Eur J Cell Biol; 1998 Apr; 75(4):383-8. PubMed ID: 9628325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibroblast growth factor and canonical WNT/β-catenin signaling cooperate in suppression of chondrocyte differentiation in experimental models of FGFR signaling in cartilage.
    Buchtova M; Oralova V; Aklian A; Masek J; Vesela I; Ouyang Z; Obadalova T; Konecna Z; Spoustova T; Pospisilova T; Matula P; Varecha M; Balek L; Gudernova I; Jelinkova I; Duran I; Cervenkova I; Murakami S; Kozubik A; Dvorak P; Bryja V; Krejci P
    Biochim Biophys Acta; 2015 May; 1852(5):839-50. PubMed ID: 25558817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.